MD3527F1 - Method of periodontitis induction - Google Patents

Method of periodontitis induction

Info

Publication number
MD3527F1
MD3527F1 MDA20070127A MD20070127A MD3527F1 MD 3527 F1 MD3527 F1 MD 3527F1 MD A20070127 A MDA20070127 A MD A20070127A MD 20070127 A MD20070127 A MD 20070127A MD 3527 F1 MD3527 F1 MD 3527F1
Authority
MD
Moldova
Prior art keywords
ammonium chloride
broth
induction
water
diethildithiocarbamate
Prior art date
Application number
MDA20070127A
Other languages
Romanian (ro)
Other versions
MD3527G2 (en
Inventor
Gheorghe GRANCIUC
Valentin Gudumac
Ion NASTAS
Original Assignee
Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova filed Critical Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority to MDA20070127A priority Critical patent/MD3527G2/en
Publication of MD3527F1 publication Critical patent/MD3527F1/en
Publication of MD3527G2 publication Critical patent/MD3527G2/en

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention refers to the experimental medicine and may be used for induction of pathologic processes in parodontium, investigation of disease pathogeny, elaboration of treatment modes and monitoring of efficiency thereof. Summary of the invention consists in the administration to the laboratory animal per os daily, in a dose of 100 ml/kg of body weight, during 4 weeks of a mixture containing ammonium chloride, sodium diethildithiocarbamate, sucrose, beef broth and distilled water in the following component ratio, to 100 ml:ammonium chloride, g�� 2,5à3,5sodium diethyldithiocarbamate, g 0,01à0,02sucrose, g��� 14,0à18,0beef broth, g��� 10,0à15,0distilled water, ml�� the rest.
MDA20070127A 2007-05-03 2007-05-03 Method of periodontitis induction MD3527G2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20070127A MD3527G2 (en) 2007-05-03 2007-05-03 Method of periodontitis induction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20070127A MD3527G2 (en) 2007-05-03 2007-05-03 Method of periodontitis induction

Publications (2)

Publication Number Publication Date
MD3527F1 true MD3527F1 (en) 2008-03-31
MD3527G2 MD3527G2 (en) 2008-10-31

Family

ID=39271499

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20070127A MD3527G2 (en) 2007-05-03 2007-05-03 Method of periodontitis induction

Country Status (1)

Country Link
MD (1) MD3527G2 (en)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1399807A1 (en) * 1985-05-23 1988-05-30 Одесский научно-исследовательский институт стоматологии Method of modeling parodontitis

Also Published As

Publication number Publication date
MD3527G2 (en) 2008-10-31

Similar Documents

Publication Publication Date Title
BRPI0411241A (en) therapeutic agents useful for treating pain
MX2009011755A (en) Combination therapy with a compound acting as a platelet adp receptor inhibitor.
NZ595526A (en) Pharmaceutical composition comprising a vla-4 binding antibody, a phosphate buffer and a surfactant
UA99094C2 (en) Method for the treatment of patients with autoantibody positive disease
NZ597378A (en) Treatment of multiple sclerosis with laquinimod
TW200609219A (en) Aryl-substituted piperazine derivatives
RU2008134874A (en) METHOD FOR INCREASING DRY MUSCULAR MASS AND REDUCING FAT TISSUE
MXPA05013856A (en) 5ht2c receptor agonists for the treatment of diabetes and obesity.
UA98462C2 (en) Methods for treating autoimmune diseases using a taci-ig fusion molecule
WO2012044783A3 (en) Method of achieving a thymosin beta 4 concentration in a human patient
TW200635925A (en) Aminium salts of 1,2,3-triazoles as prodrugs of drugs including antiviral agents
MD3527F1 (en) Method of periodontitis induction
EA200700176A1 (en) PEPTIDE, NORMALIZING METABOLISM IN BONE AND NURSING TISSUES, PHARMACEUTICAL COMPOSITION ON ITS BASIS AND METHOD OF ITS APPLICATION
UA91136C2 (en) Peptide capable of stimulating the regeneration of neurons, pharmaceutical composition based thereon and method of use thereof
NZ595798A (en) Ectoparasiticidal methods and formulations
MX2009006670A (en) Pharmaceutical composition using aliskiren and avosentan.
MX2010006310A (en) O-desmethyl-venlafaxine for treating major depressive disorder.
JP2005506959A5 (en)
RU2007100833A (en) METHOD FOR TREATING INFECTIOUS FACILITY OF THE FACIAL NERVE IN THE ACUTE PERIOD
RU2010134265A (en) METHOD FOR TREATING DYSPEPSY IN CALVES
RU2013154562A (en) METHODS AND COMPOSITIONS FOR PRESERVING THE BEAUTY BODY WEIGHT IN THE PROCESS OF SLIMMING
EA200801957A1 (en) METHOD OF INCREASING THE ADAPTABILITY OF THE ORGANISM TO PHYSICAL LOADS
RU2000103102A (en) METHOD FOR MODELING TOXIC HEPATOPATHY
UA29235U (en) Method for improving the productivity and stress resistance of piglets
BRPI0415111A (en) pharmaceutical composition comprising 5-methyl-2- (2'-chloro-6'-fluoroanilino) phenylacetic acid

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees